Contact

• workRoom Room A103
  King's Meadow Campus
  Lenton Lane
  Nottingham
  NG7 2NR
  UK
• work0115 846 8721
• Natasha.Rogers@nottingham.ac.uk
• https://www.nottingham.ac.uk/dermatology

Biography

Natasha graduated from the University of Nottingham in 2009 after completing an MSci in Biochemistry and Biological Chemistry. Remaining at the university, she attained a PhD in airway remodelling at the Division of Therapeutics & Molecular Medicine. In 2013 She joined the Centre of Evidence Based Dermatology, initially employed as a research associate and later as a research scientist specialising in evidence dissemination.

Selected Publications

• LANGE, T., KOTTNER, J., WEBERSCHOCK, T., HAHNEL, E., APFELBACHER, C., BRANDSTETTER, S., DREHER, A., DATZMANN, T., BURDEN-TEH, E., ROGERS, N. K., SPULS, P., GRAINGE, M. J., JACOBI, L., WILLIAMS, H. C. and SCHMITT, J., 2020. Outcome assessment in dermatology clinical trials and cochrane reviews: call for a dermatology-specific outcome taxonomy JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY.
• CABRIDAIN, CLEMENTINE, AUBERT, HELENE, KAEFFER, BERTRAND, BADON, VIRGINIE, BOIVIN, MARION, DOCHEZ, VINCENT, WINER, NORBERT, FAUREL-PAUL, ELODIE, PLANCHE, LUCIE, RIOCHET, DAVID, MARUANI, ANNABEL, PERROTIN, FRANCK, DROITCOURT, CATHERINE, LASSEL, LINDA, TCHING-SIN, MARTINE, ROGERS, NATASHA K., BODINIER, MARIE and BARBAROT, SEBASTIEN, 2019. Effectiveness of an antenatal maternal supplementation with prebiotics for preventing atopic dermatitis in high-risk children (the PREGRALL study): protocol for a randomised controlled trial BMJ OPEN. 9(4),
• SCHMITT, JOCHEN, LANGE, TONI, KOTTNER, JAN, PRINSEN, CECILIA A. C., WEBERSCHOCK, TOBIAS, HAHNEL, ELISABETH, APFELBACHER, CHRISTIAN, BRANDSTETTER, SUSANNE, DREHER, ANDREAS, STEVENS, GILES, BURDEN-TEH, ESTHER, ROGERS, NATASHA, SPULS, PHYLLIS, GRAINGE, MATTHEW J., WILLIAMS, HYWEL C. and JACOBI, LENA, 2019. Cochrane Reviews and Dermatological Trials Outcome Concordance: Why Core Outcome Sets Could Make Trial Results More Usable JOURNAL OF INVESTIGATIVE DERMATOLOGY. 139(5), 1045-1053
• NANKERVIS, H., THOMAS, K. S., DELAMERE, F. M., BARBAROT, S., ROGERS, N. K. and WILLIAMS, H. C., 2016. Scoping systematic review of treatments for eczema: Programme Grants Appl Res Programme Grants Appl Res. 4(7), 1-480

• View all publications

• OLABI B, WORBOYS S, GARLAND T, GRINDLAY DJC, ROGERS NK and HARMAN KE, 2020. What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 2: systemic therapies. Clinical and experimental dermatology. (In Press.)
• LANGE, T., KOTTNER, J., WEBERSCHOCK, T., HAHNEL, E., APFELBACHER, C., BRANDSTETTER, S., DREHER, A., DATZMANN, T., BURDEN-TEH, E., ROGERS, N. K., SPULS, P., GRAINGE, M. J., JACOBI, L., WILLIAMS, H. C. and SCHMITT, J., 2020. Outcome assessment in dermatology clinical trials and cochrane reviews: call for a dermatology-specific outcome taxonomy JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY.
• SOLMAN L, LLOYD-LAVERY A, GRINDLAY DJC, ROGERS NK, THOMAS KS and HARMAN KE, 2019. What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 1: treatment and prevention. Clinical and experimental dermatology. 44(4), 363-369
• LLOYD-LAVERY A, SOLMAN L, GRINDLAY DJC, ROGERS NK, THOMAS KS and HARMAN KE, 2019. What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 3: nomenclature and outcome assessment. Clinical and experimental dermatology. 44(4), 376-380
• LLOYD-LAVERY A, SOLMAN L, GRINDLAY DJC, ROGERS NK, THOMAS KS and HARMAN KE, 2019. What's new in atopic eczema? An analysis of systematic reviews published in 2016. Part 2: Epidemiology, aetiology and risk factors. Clinical and experimental dermatology. 44(4), 370-375
• WERNHAM AGH, VEITCH D, GRINDLAY DJC, ROGERS NK and HARMAN KE, 2019. What's new in atopic eczema? An analysis of systematic reviews published in 2017. Part 1: treatment and prevention. Clinical and experimental dermatology. 44(8), 861-867
• HALE G, DAVIES E, GRINDLAY DJC, ROGERS NK and HARMAN KE, 2019. What's new in atopic eczema? An analysis of systematic reviews published in 2017. Part 2: epidemiology, aetiology and risk factors. Clinical and experimental dermatology. 44(8), 868-873
• L.HOWELLS, CHALMERS JR, GRAN S, AHMED A, APFELBACHER C, BURTON T, HOWIE L, LAWTON S, RIDD M, ROGERS NK, SEARS AV, SPULS P and THOMAS KS, 2019. Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP) Br J Dermatol.
• CABRIDAIN, CLEMENTINE, AUBERT, HELENE, KAEFFER, BERTRAND, BADON, VIRGINIE, BOIVIN, MARION, DOCHEZ, VINCENT, WINER, NORBERT, FAUREL-PAUL, ELODIE, PLANCHE, LUCIE, RIOCHET, DAVID, MARUANI, ANNABEL, PERROTIN, FRANCK, DROITCOURT, CATHERINE, LASSEL, LINDA, TCHING-SIN, MARTINE, ROGERS, NATASHA K., BODINIER, MARIE and BARBAROT, SEBASTIEN, 2019. Effectiveness of an antenatal maternal supplementation with prebiotics for preventing atopic dermatitis in high-risk children (the PREGRALL study): protocol for a randomised controlled trial BMJ OPEN. 9(4),
• SCHMITT, JOCHEN, LANGE, TONI, KOTTNER, JAN, PRINSEN, CECILIA A. C., WEBERSCHOCK, TOBIAS, HAHNEL, ELISABETH, APFELBACHER, CHRISTIAN, BRANDSTETTER, SUSANNE, DREHER, ANDREAS, STEVENS, GILES, BURDEN-TEH, ESTHER, ROGERS, NATASHA, SPULS, PHYLLIS, GRAINGE, MATTHEW J., WILLIAMS, HYWEL C. and JACOBI, LENA, 2019. Cochrane Reviews and Dermatological Trials Outcome Concordance: Why Core Outcome Sets Could Make Trial Results More Usable JOURNAL OF INVESTIGATIVE DERMATOLOGY. 139(5), 1045-1053
• DAVIES E, ROGERS NK, LLOYD-LAVERY A, GRINDLAY DJC and THOMAS KS, 2018. What's new in atopic eczema? An analysis of systematic reviews published in 2015. Part 1: epidemiology and methodology. Clinical and experimental dermatology. 43(4), 375-379
• CHALMERS JR, THOMAS KS, APFELBACHER C, WILLIAMS HC, PRINSEN CA, SPULS PI, SIMPSON E, GERBENS LAA, BOERS M, BARBAROT S, STALDER JF, ABUABARA K, AOKI V, ARDELEANU M, ARMSTRONG J, BANG B, BERENTS TL, BURTON T, BUTLER L, CHUBACHI T, CRESSWELL-MELVILLE A, DELOZIER A, ECKERT L, EICHENFIELD L, FLOHR C, FUTAMURA M, GADKARI A, GJERDE ES, VAN HALEWIJN KF, HAWKES C, HOWELLS L, HOWIE L, HUMPHREYS R, ISHII HA, KATAOKA Y, KATAYAMA I, KOUWENHOVEN W, LANGAN SM, LESHEM YA, MERHAND S, MINA-OSORIO P, MUROTA H, NAKAHARA T, NUNES FP, NYGAARD U, NYGÅRDAS M, OHYA Y, ONO E, REHBINDER E, ROGERS NK, ROMEIJN GLE, SCHUTTELAAR MLA, SEARS AV, SIMPSON MA, SINGH JA, SROUR J, STUART B, SVENSSON Å, TALMO G, TALMO H, TEIXEIRA HD, THYSSEN JP, TODD G, TORCHET F, VOLKE A, VON KOBYLETZKI L, WEISSHAAR E, WOLLENBERG A and ZANIBONI M, 2018. Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). The British journal of dermatology. (In Press.)
• LLOYD-LAVERY A, ROGERS NK, DAVIES E, GRINDLAY DJC and THOMAS KS, 2018. What's new in atopic eczema? An analysis of systematic reviews published in 2015. Part 2: prevention and treatment. Clinical and experimental dermatology. 43(6), 653-658
• LLOYD-LAVERY A, ROGERS NK, HATFIELD SJ, GRINDLAY D, BARNETT R and THOMAS KS, 2017. What's new in atopic eczema? An analysis of systematic reviews published in 2014. Part 2. Treatment and prevention. Clinical and experimental dermatology. 42(1), 3-7
• LLOYD-LAVERY, A., ROGERS, N. K., HATFIELD, S. J., GRINDLAY, D., BARNETT, R. and THOMAS, K. S., 2017. What's new in atopic eczema? An analysis of systematic reviews published in 2014. Part 2. Treatment and prevention: Clin Exp Dermatol Clin Exp Dermatol. 42(1), 3-7
• NANKERVIS, H., THOMAS, K. S., DELAMERE, F. M., BARBAROT, S., SMITH, S., ROGERS, N. K. and WILLIAMS, H. C., 2017. What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials: Br J Dermatol Br J Dermatol. 176(4), 910-927
• CHAUHAN DN, WILKES SR, RATIB S, DONEY E, BATCHELOR JM and ROGERS NK, 2016. Risk of bias does not differ between full papers and letters reporting dermatological randomised controlled trials British journal of dermatology. 175(1), 210-1
• BARBAROT, S., ROGERS, N. K., ABUABARA, K., AUBERT, H., CHALMERS, J., FLOHR, C., HANIFIN, J., NALDI, L., MARGOLIS, D. J., PAUL, C., RIDD, M. J., ANNA SCHUTTELAAR, M. L., SIMPSON, E., TAUBER, M., VOLKE, A., WEIDINGER, S., WILKES, S. R., WOLLENBERG, A. and THOMAS, K. S., 2016. Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review: J Am Acad Dermatol J Am Acad Dermatol.
• GERBENS, L. A., CHALMERS, J. R., ROGERS, N. K., NANKERVIS, H. and SPULS, P. I., 2016. Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic review: Br J Dermatol Br J Dermatol. 175(4), 678-686
• NANKERVIS, H., THOMAS, K. S., DELAMERE, F. M., BARBAROT, S., SMITH, S., ROGERS, N. K. and WILLIAMS, H. C., 2016. What is the evidence-base for atopic eczema treatments? A summary of published randomised controlled trials: Br J Dermatol Br J Dermatol.
• HATFIELD SJ, ROGERS NK, LLOYD-LAVERY A, GRINDLAY D, BARNETT R and THOMAS KS, 2016. What's new in atopic eczema? An analysis of systematic reviews published in 2014. Part 1. Epidemiology, risk factors and outcomes. Clinical and experimental dermatology. 41(8), 843-846
• NANKERVIS H, THOMAS KS, DELAMERE FM, BARBAROT S, SMITH S, ROGERS NK and WILLIAMS HC, 2016. What is the evidence-base for atopic eczema treatments? A summary of published randomised controlled trials. The British journal of dermatology. (In Press.)
• BARBAROT S, ROGERS NK, ABUABARA K, AUBERT H, CHALMERS J, FLOHR C, HANIFIN J, NALDI L, MARGOLIS DJ, PAUL C, RIDD MJ, ANNA SCHUTTELAAR ML, SIMPSON E, TAUBER M, VOLKE A, WEIDINGER S, WILKES SR, WOLLENBERG A and THOMAS KS, 2016. Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review. Journal of the American Academy of Dermatology. 75(5), 1038-1044
• HATFIELD, S. J., ROGERS, N. K., LLOYD-LAVERY, A., GRINDLAY, D., BARNETT, R. and THOMAS, K. S., 2016. What's new in atopic eczema? An analysis of systematic reviews published in 2014. Part 1. Epidemiology, risk factors and outcomes: Clin Exp Dermatol Clin Exp Dermatol. 41(8), 843-846
• NANKERVIS, H., THOMAS, K. S., DELAMERE, F. M., BARBAROT, S., ROGERS, N. K. and WILLIAMS, H. C., 2016. Scoping systematic review of treatments for eczema: Programme Grants Appl Res Programme Grants Appl Res. 4(7), 1-480
• CHAUHAN, D. N., WILKES, S. R., RATIB, S., DONEY, E., BATCHELOR, J. M., ROGERS, N. K. and WILLIAMS, H. C., 2016. Risk of bias does not differ between full papers and letters reporting dermatological randomized controlled trials: Br J Dermatol Br J Dermatol. 175(1), 210-1
• ROGERS NK, CLEMENTS D, DONGRE A, HARRISON TW, SHAW D and JOHNSON SR, 2014. Expression of Tenascin-C in Airway Remodelling in Asthma induces Metalloproteinase-1 activity and increases Airway Smooth Muscle Contraction. Plos One. 9(2), e90565
• ROGERS, N., PAINE, S., BEDFORD, L. and LAYFIELD, R., 2010. Review: the ubiquitin-proteasome system: contributions to cell death or survival in neurodegeneration: Neuropathol Appl Neurobiol Neuropathol Appl Neurobiol. 36(2), 113-24